Current NDC auxiliary source row compounder:4772

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5502
Product Ndc: 26436-5502
Product Ndc Digits: 264365502
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Biest 0.45mg Progesterone 20mg Testosterone 0.4mg/gm
Proprietary Name Suffix: [empty]
Nonproprietary Name: Biest 0.45mg Progesterone 20mg Testosterone 0.4mg/gm
Dosage Form Name: CREAM
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: ESTRIOL; TESTOSTERONE; ESTRADIOL; PROGESTERONE
Active Ingredients Info: .225 mg/1 g; .4 mg/1 g; .225 mg/1 g; 20 mg/1 g
History Active Ingredients Raw: ESTRIOL; TESTOSTERONE; ESTRADIOL; PROGESTERONE
History Active Ingredients Info Raw: .225 mg/1 g; .4 mg/1 g; .225 mg/1 g; 20 mg/1 g
History Dosage Raw: CREAM
Dea Schedule: CIII
Package Ndc Raw: 26436-5502-3
Package Ndc: 26436-5502-3
Package Ndc Digits: 2643655023
Package Ndc11: 26436550203
Package Description: 30 g in 1 BOTTLE, PUMP (26436-5502-3)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4772
Source Row Number: 4772
Source Row Hash: 13091969163c83c55f7c8d29dc88382edf61467df2c9a4b62058be2351e04210
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "26436-5502",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "ESTRIOL; TESTOSTERONE; ESTRADIOL; PROGESTERONE",
    "DOSAGEFORMNAME": "CREAM",
    "NDCPACKAGECODE": "26436-5502-3",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Biest 0.45mg Progesterone 20mg Testosterone 0.4mg/gm",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Biest 0.45mg Progesterone 20mg Testosterone 0.4mg/gm",
    "PACKAGEDESCRIPTION": "30 g in 1 BOTTLE, PUMP (26436-5502-3) ",
    "ACTIVEINGREDIENTSINFO": ".225 mg/1 g; .4 mg/1 g; .225 mg/1 g; 20 mg/1 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4772
Source Row Number: 4772
Status Scope: package
Lookup Ndc: 26436-5502-3
Lookup Ndc Digits: 2643655023
Product Ndc: 26436-5502
Product Ndc Digits: 264365502
Package Ndc: 26436-5502-3
Package Ndc Digits: 2643655023
Package Ndc11: 26436550203
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 13091969163c83c55f7c8d29dc88382edf61467df2c9a4b62058be2351e04210
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33